CSIMarket



Zimmer Biomet Holdings, Inc.  (ZMH)
Other Ticker:  
 
 

ZMH's Revenue Growth by Quarter and Year

Zimmer Biomet Holdings,'s Revenue results by quarter and year




ZMH Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
IV Quarter December - 1,222.90 1,240.70 1,180.50
III Quarter September 1,762.20 1,106.00 1,074.30 1,025.50
II Quarter June 1,167.60 1,182.90 1,169.50 1,125.00
I Quarter March 1,134.40 1,161.50 1,138.90 1,140.70
FY   4,064.20 4,673.30 4,623.40 4,471.70



ZMH Revenue third quarter 2015 Y/Y Growth Comment
Zimmer Biomet Holdings, Inc. showed record Revenue increase in the third quarter 2015 with 59.33% from the third quarter 2015 2014, to $ 1,762.20 millions.

Looking into third quarter 2015 results within Medical Equipment & Supplies industry 111 other companies have achieved higher Revenue growth. While Zimmer Biomet Holdings, Inc.' s Revenue jump of 59.33% ranks overall at the positon no. 2783 in the third quarter 2015.




ZMH Revenue ( Y/Y Growth %) 2015
2014 2013 2012
IV Quarter December - -1.43 % 5.1 % 1.13 %
III Quarter September 59.33 % 2.95 % 4.76 % -0.58 %
II Quarter June -1.29 % 1.15 % 3.96 % -1.09 %
I Quarter March -2.33 % 1.98 % -0.16 % 2.25 %
FY   - 1.08 % 3.39 % 0.45 %

Financial Statements
Zimmer Biomet Holdings,'s third quarter 2015 Revenue $ 1,762.20 millions ZMH's Income Statement
Zimmer Biomet Holdings,'s third quarter 2014 Revenue $ 1,106.00 millions Quarterly ZMH's Income Statement
New: More ZMH's historic Revenue Growth >>


ZMH Revenue (Quarter on Quarter Growth %)

2015
2014 2013 2012
IV Quarter December - 10.57 % 15.49 % 15.11 %
III Quarter September 50.92 % -6.5 % -8.14 % -8.84 %
II Quarter June 2.93 % 1.84 % 2.69 % -1.38 %
I Quarter March -7.24 % -6.38 % -3.52 % -2.28 %
FY (Year on Year)   - 1.08 % 3.39 % 0.45 %




Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #381
Overall #2783

Revenue Y/Y Growth Statistics
High Average Low
59.33 % 5.89 % -6.29 %
(Sep. 30, 2015)  
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #381
Overall #2783
Revenue Y/Y Growth Statistics
High Average Low
59.33 % 5.89 % -6.29 %
(Sep. 30, 2015)  

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Zimmer Biomet Holdings,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
50.92 % 2.49 % -11.79 %
(Sep. 30, 2015)  


ZMH's III. Quarter Q/Q Revenue Comment
Zimmer Biomet Holdings, Inc. achieved in the III. Quarter 2015 above company average sequential Revenue jump of 50.92%, to $ 1,762.20 millions, from $1,167.60 millions in the second quarter.
Zimmer Biomet Holdings, is impressively improving, not only claiming better then regular growth, and additionally increasing rate, Benjamin Cook, market observer mentioned.

Within Medical Equipment & Supplies industry 89 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings,'s Revenue growth quarter on quarter, overall rank is 2262.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #306
Overall #2262
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #90
Healthcare Sector #306
Overall #2262
Revenue Q/Q Growth Statistics
High Average Low
50.92 % 2.49 % -11.79 %
(Sep. 30, 2015)  


ZMH's III. Quarter Q/Q Revenue Comment
Zimmer Biomet Holdings, Inc. achieved in the III. Quarter 2015 above company average sequential Revenue jump of 50.92%, to $ 1,762.20 millions, from $1,167.60 millions in the second quarter.
Medical Equipment & Supplies company is going from strength to strength, not only recording above average gain, but also increasing rate.

Within Medical Equipment & Supplies industry 89 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings,'s Revenue growth quarter on quarter, overall rank is 2262.


Zimmer Biomet Holdings,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep. 30, 2015)
12 Months Ending
(June 30. 2015)
12 Months Ending
(March 31, 2015)
12 Months Ending
(Dec. 30, 2014)
12 Months Ending
(Sep. 30, 2014)
Cumulative Revenue 12 Months Ending $ 5,287.10 $ 4,630.90 $ 4,646.20 $ 4,673.30 $ 4,691.10
Y / Y Revenue Growth (TTM) 12.7 % -0.61 % 0 % 1.08 % 2.8 %
Year on Year Revenue Growth Overall Ranking # 2263 # 2547 # 2547 # 0 # 2551
Seqeuential Revenue Change (TTM) 14.17 % -0.33 % -0.58 % -0.38 % 0.68 %
Seq. Revenue Growth (TTM) Overall Ranking # 2162 # 2842 # 2844 # 0 # 2396




Cumulative Revenue growth Comment
Zimmer Biomet Holdings, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 12.7% year on year, to $ 5,287 millions if the fiscal year would have ended in Sep. 30, 2015.
Zimmer Biomet Holdings,'s trailing twelve months Revenue growth was higher than company's average 6.54% and higher than -0.61% growth in June 30. 2015.
The growth was even higher sequentially showed at 14.17 % increase from $4630.9 millions in twelve months ending a quarter June 30. 2015.

In the Healthcare sector 265 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2263, from total ranking in previous quarter at 2547.

Revenue TTM Q/Q Growth Statistics
High Average Low
75.45 %
3.08 %
-1.62 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 266
Overall # 2263

Revenue TTM Y/Y Growth Statistics
High Average Low
79.04 %
6.54 %
-3.51 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 269
S&P 500 # 2162
Cumulative Revenue growth Comment
Zimmer Biomet Holdings, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 12.7% year on year, to $ 5,287 millions if the fiscal year would have ended in Sep. 30, 2015.
Zimmer Biomet Holdings,'s trailing twelve months Revenue growth was higher than company's average 6.54% and higher than -0.61% growth in June 30. 2015.
The progress was even more impressive sequentially clinched at 14.17 % jump from $4630.9 millions in twelve months ending a quarter before.

In the Healthcare sector 265 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2263, from total ranking in previous quarter at 2547.

Revenue TTM Q/Q Growth Statistics
High Average Low
75.45 %
3.08 %
-1.62 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 266
Overall # 2263

Revenue TTM Y/Y Growth Statistics
High Average Low
79.04 %
6.54 %
-3.51 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 269
S&P 500 # 2162




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ZMH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ZMH's Competitors
Revenue Growth for Zimmer Biomet Holdings,'s Suppliers
Revenue Growth for ZMH's Customers

You may also want to know
ZMH's Annual Growth Rates ZMH's Profitability Ratios ZMH's Asset Turnover Ratio ZMH's Dividend Growth
ZMH's Roe ZMH's Valuation Ratios ZMH's Financial Strength Ratios ZMH's Dividend Payout Ratio
ZMH's Roa ZMH's Inventory Turnover Ratio ZMH's Growth Rates ZMH's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Sep. 30, 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep. 30, 2015
Assertio Holdings inc 103.66%$ 103.663 millions
Clearpoint Neuro Inc 96.85%$ 96.846 millions
Lineage Cell Therapeutics Inc 93.60%$ 93.602 millions
Akorn Inc93.47%$ 93.473 millions
Vanda Pharmaceuticals Inc 91.75%$ 91.747 millions
Chimerix inc.91.65%$ 91.646 millions
Ekimas Corporation87.91%$ 87.906 millions
Delcath Systems Inc 83.87%$ 83.871 millions
Corcept Therapeutics Inc82.11%$ 82.107 millions
Davita Inc 79.29%$ 79.292 millions
Nevro Corp 77.69%$ 77.688 millions
Navidea Biopharmaceuticals Inc.76.85%$ 76.851 millions
Joway Health Industries Group Inc 74.86%$ 74.861 millions
Axogen inc 74.55%$ 74.547 millions
Teligent Inc 74.19%$ 74.190 millions
Semler Scientific inc 74.14%$ 74.136 millions
Vertex Pharmaceuticals Inc73.09%$ 73.094 millions
Regulus Therapeutics Inc 72.21%$ 72.207 millions
Lifemd Inc 69.15%$ 69.146 millions
Theravance Biopharma inc 68.84%$ 68.845 millions
Antares Pharma Inc 68.72%$ 68.718 millions
Oragenics Inc 64.07%$ 64.069 millions
China Yct International Group, Inc.62.83%$ 62.825 millions
Zimmer Biomet Holdings, Inc.59.33%$ 59.331 millions
Diplomat Pharmacy Inc 59.00%$ 59.004 millions
Pro dex Inc 57.88%$ 57.881 millions
Aac Holdings, Inc.56.76%$ 56.758 millions
Biospecifics Technologies Corp56.74%$ 56.745 millions
Regeneron Pharmaceuticals Inc 56.72%$ 56.715 millions
Insys Therapeutics, Inc.56.58%$ 56.584 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GSS's Profile

Stock Price

GSS's Financials

Business Description

Fundamentals

Charts & Quotes

GSS's News

Suppliers

GSS's Competitors

Customers & Markets

Economic Indicators

GSS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071